Blog

Význam integrovaného testu ve screeningu Downova syndromu

06.06.2018
Authors: Springer D, Loucky J, Tesner P, Cutka D, Stejskal D, Gregor V, Zima T
Source: J Med Screen 2018 Jan 01.:969141317752533.

Abstract

Objective In the Czech Republic, over 97% of all pregnant women undergo some type of antenatal screening for Down's syndrome. In about 95% of cases with a confirmed fetal chromosomal abnormality, the pregnancy is terminated. The most commonly used test is the first trimester combined test. We investigated the impact of implementing an integrated sequential test to improve the detection of Down's syndrome pregnancies. Methods Data on the incidence of congenital defects, number of births, and affected pregnancies terminated are recorded in the National Registry of Congenital Anomalies. Anonymous data on cases of Down's syndrome diagnosed antenatally or postnatally between 2010 and 2015 in one of the large antenatal care centers were analyzed. Results There were 600 diagnoses of Down's syndrome (5.7 per 1000 births), 90% of which were made antenatally. Of antenatally detected cases, 80% were indicated for diagnostic procedure by multimarker screening results. In the multimarker screen positive group, 75% cases were first trimester positive and 25% second trimester positive (most of these had positive integrated test results). Among Down's syndrome cases indicated for antenatal diagnosis by multimarker screening results 6.25% (n = 26) were first trimester negative, and became positive after integration with the second trimester screening results. Conclusions Results from five major Czech antenatal centers confirm that an integrated sequential test would detect 80-85% of Down's syndrome fetuses in the first trimester and at least an extra 5-10% of Down's syndrome pregnancies in the second trimester of pregnancy. These are important data that should be considered in implementing the national antenatal screening program.

 

 


Mohlo by vás zajímat

Novinka
04.10.2022

Vážení klienti, rádi bychom vám oznámili, že ve dnech od 10. 10. 2022 – 14. 10. 2022 a následně od 31. 10. – 11. 11. 2022 bude mít MUDr. Viktor Vik dovolenou. MUDr. Jan Novák je do konce roku na stáži v Německu.

Novinka
27.09.2022

Vážené klientky a klienti, z důvodu státního svátku ve středu 28. 9. bychom Vás rádi informovali, že provoz klinik je omezen pouze pro objednané. Děkujeme za pochopení, Váš GENNET

Novinka
16.09.2022

Vážené klientky a klienti,  GENNET se stal partnerem Světového dne trombózy a v OC Plaza Liberec se můžete ve čtvrtek 13. 10. 2022  rychle a bezbolestně vyšetřit na přítomnost trombofilních mutací.   

Novinka
14.07.2022

Vážené klientky, vážení klienti, rádi bychom Vás informovali, že od začátku léta došlo k přesunům IVF lékařů v rámci poboček GENNET. S paní MUDr. Veronikou Mokrou se tak můžete nově potkat na pobočce GENNET Praha 7 a MUDr. Sergiu Leahomschi naopak změnil působení z pražské pobočky za GENNET Liberec. Přejeme Vám hezké léto! Váš GENNET